An interdependent ecosystem of production and delivery is needed in #advancedtherapies. Enter #Vineti’s cloud-based, validated Personalized Therapy Management (PTM®) platform where together with our network, we deliver integrated solutions for even greater success.
PTM Essentials™ solution is a turnkey cell & gene therapy #clinicaltrial accelerator that provides critical infrastructure for personalized therapy studies. Benefits include affordability, fast implementation & much more: https://t.co/5WQIYBwSQe #AccelerateClinicalTrials
#Vineti Compliance Officer and SVP of Quality, Security, and Compliance, @buzzublade, joins industry experts to discuss managing, simplifying, and scaling transformative, complicated clinical trials. Download the Q&A: https://t.co/jyiblRpXgh #CellTherapy#GeneTherapy#Biotech
Looking to get involved in the @SCBRegenMed? It doesn't matter if you're new to standards or an industry expert, there are several different ways you can join the standards advancement process. To learn more, visit: https://t.co/n4hWpvalul
Vice President of Professional Services at Vineti, Stefan Koch, is highlighting how we are making implementations in complex cell and gene therapies simpler and faster using a proven approach. Read the full article: https://t.co/olhy54qKsC #celltherapy#genetherapy
Don't miss #Vineti CEO, Ann Klein, speak on a panel about the next-generation supply chain for cell & gene therapies at @PMWCintl. Ann will join industry experts to discuss supply chain challenges and solutions in advanced therapies.
Learn more: https://t.co/XFE63TpnPc #PMWC22
Find out how our software allows you to manage compliance and quality while keeping every product journey on time and on track: https://t.co/t0vSaPcEhI #advancingwhatspossible
Did you know our PTM® platform provides permanent and transparent association of a therapy to the complete record of all activities involved from end to end?
Breakthrough treatments require innovation at every level, including the underlying digital technology that drives production, patient safety, delivery & reimbursement. That's where #Vineti's PTM® platform comes in. Discover our one-of-a-kind technology: https://t.co/Xt0rnPRGAb
Stefan Koch, VP of Professional Services at #Vineti, dives into how we're making implementations in complex #cellandgenetherapies simpler and faster using a proven approach that we've developed through years of direct CGT experience.
Learn more: https://t.co/olhy54qKsC
In life sciences, #cybersecurity should be top of mind as this industry is vulnerable & increasingly targeted. If you're wondering how to stay protected, we've put together top strategies to provide the building blocks for a strong approach to security: https://t.co/Yh12u3jhHQ
As the proven clinical-to-commercial platform for cell and gene therapy supply chain management, part of our mission is to open up access to #advancedtherapies and share collective insights for industry growth. Learn more ⤵️ https://t.co/rceW8or7vb
Our PTM® Integration Suite brings a purpose-built integration solution via API to highly complex, distributed #celltherapy and #genetherapy workflows.
Discover what it's all about ⤵️ #patientfirst#advancingwhatspossible https://t.co/VTjTSofA1H
Read why Vineti's COO, Louise Pacini, believes the comprehensive value in cell and gene therapies lies in both the therapy itself and the value chain that supports it: https://t.co/rNNZSEafc3 #celltherapy#genetherapy
Thank you Supply Chain & Logistics for Cell Therapies Summit for having us! Vineti's Marc Puich enjoyed seeing all of the new and familiar faces in person and getting to hear from industry leaders in the cell and gene therapy space. #celltherapy#genetherapy
At a price point that works for early-phase projects, it's designed to grow with you as you scale to commercialization or expand into new geographic and therapeutic areas.
Learn more: https://t.co/5WQIYBNVSe #accelerateclinicaltrials#advancingwhatspossible#Vineti
Not only is it the first, but our PTM Essentials™ continues to be proven as the top platform when it comes to providing the most critical clinical trial capabilities.
Find out what our recommended approach to COI is and why we believe it's crucial to the success of our industry: https://t.co/dbkKrdFai1 #celltherapy#genetherapy#vineti
COI (Chain of Identity) is at the core of everything we do. In a post by our Manager of Product Management, Amy Fonte, this very component is addressed in regards to the @US_FDA's recent draft guidance documents for the cell & gene therapies that were made available for comment.